We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

170 hedge funds and large institutions have $591M invested in Avid Bioservices, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 72 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

9% more call options, than puts

Call options by funds: $105K | Put options by funds: $96K

1% more funds holding

Funds holding: 169170 (+1)

28% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 72

35% less capital invested

Capital invested by funds: $907M → $591M (-$316M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
170
Holders Change
+1
Holders Change %
+0.59%
% of All Funds
2.7%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
21
Increased
52
Reduced
72
Closed
19
Calls
$105K
Puts
$96K
Net Calls
+$9K
Net Calls Change
+$94K

CDMO Hedge Fund Activity: Q3 2023 in Review

170 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2023, worth a combined $591M — down 35% from $907M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new CDMO positions and 19 closed out — a net gain of 2 holders — while 52 added to existing stakes and 72 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $11.2M. The largest seller was Fidelity Investments, cutting an estimated $17.4M.

  • 170 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2023, up from 169 in Q2 2023.
  • Funds reported $591M of Avid Bioservices, Inc. Common Stock stock for Q3 2023, down 35% quarter-over-quarter.
  • 21 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2023 and 19 closed out, a net change of +2 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2023 was Citadel Advisors, an estimated $11.2M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q3 2023 was Fidelity Investments, an estimated $17.4M sold.

Based on aggregated 13F filings for Q3 2023.